Wantai Biopharm’s Cecolin 9 HPV Vaccine Approved by China’s NMPA
China-based Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392) announced that its 9-valent human...
Vaccine
Gilead Sciences to Acquire Hookipa’s HB-400 and HB-500 Vaccine Programs
US-based Gilead Sciences Inc. (Nasdaq: GILD) announced plans to acquire the HB-400 and HB-500 programs...
Chongqing Genrix Bio’s GR2001 Tetanus Monoclonal Antibody NDA Accepted by NMPA
China-based Chongqing Genrix Bio Pharmaceutical Co., Ltd (SHA: 688443) recently announced that its New Drug...
China’s AIM Vaccine Launches Clinical Trials for mRNA Shingles Vaccine in China and US
China-based AIM Vaccine Co., Ltd (HKG: 6660) announced the initiation of clinical trials for its...
North China Pharma Wins NMPA Approval for Clinical Trials of Recombinant Tetanus Vaccine
China-based North China Pharmaceutical Group Corporation (SHA: 600812) announced that it has received clinical trial...
CanSino Biologics Gets Indonesian Approval for Phase I Trial of Inhalable Tuberculosis Vaccine
China-based CanSino Biologics Inc. (HKG: 6185), a specialist in vaccine development, has announced that it...
Sinovac Biotech Gains Hong Kong Approval for Influenza Vaccines
China-based Sinovac Biotech Ltd (NASDAQ: SVA) announced that it has received marketing approvals from the...
Abogen’s ABO2102 mRNA Cancer Vaccine Gets US Clinical Trial Approval
China’s Abogen Biosciences Co., Ltd, a developer of messenger ribonucleic acid (mRNA) drugs, announced that...
Pfizer’s Q1 2025 Results: Revenues Down 6% YOY Amid Paxlovid, IRA Impact
US-based Pfizer Inc. (NYSE: PFE) released its Q1 2025 financial results, showing a -6% year-on-year...
Merck Q1 2025 Results: Keytruda Sales Grow 6% Despite Gardasil Dip in China
Global pharmaceutical company Merck (NYSE: MRK) released its Q1 2025 financial results, showing total sales...
Sanofi Reports Q1 Sales Growth Driven by Dupixent and New Product Launches
French pharmaceutical giant Sanofi (NASDAQ: SNY) released its Q1 2025 financial results, reporting global net...
Delonix Partners with WuXi Vaccines to Advance OMV Plus Platform for Bacterial Vaccines
China-based Delonix Bioworks Ltd., a developer of genetically engineered bacterial vaccines, has entered into a...
Walvax Biotech Gains NMPA Clinical Clearance for 20-Valent Pneumococcal Vaccine
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) has announced receiving clinical trial clearance from the...
Beijing Wantai Launches Phase III Trial for 9-Valent HPV Vaccine in Chinese Males
China-based Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392) has initiated a Phase III...
MSD’s Gardasil 9 Approved in China for Males Aged 16 to 26
US pharmaceutical major Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced marketing approval from...
CK Life Sciences Reports Promising Preclinical Results for TROP2-Targeted Cancer Vaccine
China-based CK Life Sciences (HKG: 0775) has announced positive early results from preclinical studies of...
Kangtai Biological’s Pentavalent Rotavirus Vaccine Enters Phase III Trials
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) announced the enrollment of the first patient...
Zhifei Biological Gains Bangladesh Approval for Dysentery Vaccine Trial
China-based Chongqing Zhifei Biological Co., Ltd (SHE: 300122) has received clearance from the Directorate General...
AIM Vaccine’s Serum-Free Rabies Vaccine Accepted for Review by NMPA
China-based AIM Vaccine Co., Ltd (HKG: 6660) announced that its market filing for a serum-free...
Sinovac Partners with CPMA to Advance Vaccine Preventable Disease Initiatives
China-based Sinovac Biotech Ltd (NASDAQ: SVA) has entered into a strategic memorandum of understanding (MoU)...